News

Biomoda has entered into a final stage of patient testing in the phase II clinical trial of it’s early-stage diagnostic for lung cancer. The next stage of the

Medgenics has signed a preclinical development and option agreement with an international biopharmaceutical company. The agreement is worth up to $7m in payments that will include funding for

MPI Research has announced that it will be collaborating with Kineta. MPI Research will assist Kineta with advancing their autoimmune drug development program. The company said that the

Camfil Farr has been working closely with the capital projects team at Pfizer global research and development to help them realise significant savings on existing HVAC plant serving

The European Commission has granted marketing authorisation to Novartis for its Exforge HCT, a new 3-in-1 treatment for people with high blood pressure. Exforge HCT combines the efficacy

Aldevron has announced that the company is expanding into Madison, WI. The new division will produce and sell contract research and manufacturing services marketed under the Aldevron brand.

The Medicines company has announced that the Committee for Medicinal Products for Human Use (CHMP) has granted a positive opinion applicable to all Member States of the EU/European

Merck and Schering-Plough have received clearance from the European Commission (EC) under the EC Merger Regulation for their proposed merger. Reportedly, the integration planning teams from Merck and

Bayer HealthCare and Onyx Pharmaceuticals (Onyx) have initiated patient enrollment in an international phase III trial. The study is to evaluate Nexavar (sorafenib) tablets for the treatment of